|
|
| Model Number |
100043-04 |
| Medical Device Problem Code |
Patient-Device Incompatibility (2682)
|
| Health Effect - Clinical Code |
Hematoma (1884)
|
| Date of Event |
01/28/2019
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Based on the information provided, no conclusions can be made.As reported, patient experienced the post-op complication of hematoma and underwent surgery.Medical affairs has assessed the patient¿s postoperative course as being serious and likely related to the study device.Hematoma is a known inherent risk of the surgery/use of the device and listed as a possible complication in the adverse reaction section of the instruction for use (ifu) supplied with the device.Note: this mdr report is related to a retrospective study conducted to proactively gather real-world evidence on the use and safety of the p4hb product family, including galaflex scaffold, galaflex 3d, and galaflex 3dr.All safety events from the study are adjudicated by the bd medical monitor for an independent assessment of severity and relatedness.In an abundance of caution, events for which relatedness cannot be ruled out are processed for mdr reporting.Not returned - remains implanted.
|
| |
|
Event or Problem Description
|
|
Per clinical trial (b)(4): on (b)(6) 2019, patient underwent left revision augmentation; implant rupture, using a full vertical and horizontal t incision.2 pieces of galaform (galaflex 3dr) were used.Concomitant procedures included bilateral capsulectomies, bleph, facial fat grafting & laser.On (b)(6) 2019, left breast hematoma was reported.On (b)(6) 2019, patient had procedure where hematoma was evacuated.Resolved without sequelae on (b)(6) 19.Review by medical affairs identifies the reported hematoma as likely related to the device and serious.
|
| |
|
Search Alerts/Recalls
|
|
|